Heterotopic ossification happens when bone grows outside of its normal location and into the surrounding soft tissues of your body. When this happens, the pieces of bone that develop are called ...
PARIS, FRANCE, 19 December 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the pivotal Phase II FALKON trial did not meet its ...
Heterotopic ossification consists of ectopic bone formation within soft tissues after surgery or trauma. It can have debilitating consequences, but there is no definitive cure. Here we show that ...
Please provide your email address to receive an email when new articles are posted on . Tranexamic acid may be indicated for the prevention of heterotopic ossification. Patients undergoing surgery for ...
Neurogenic heterotopic ossification (NHO) is a frequent complication in spinal cord injury (SCI) that is often difficult to treat. This review emphasizes the incidence, risk factors and clinical signs ...
Nw study findings implicate a specific type of immune cell behind heterotopic ossification, or abnormal bone formation and present a possible target for treatment. Hip replacements, severe burns, ...
LAS VEGAS — The risk for heterotopic ossification after hip arthroscopy is 11 times lower when the nonsteroidal anti-inflammatory drug (NSAID) naproxen is used, a new study shows. The effect was so ...
- Initial NHHO study targets patients with traumatic SCI who have high rates of HO, which causes abnormal bone growth in soft tissues - BRISBANE, Calif.--(BUSINESS WIRE)--āshibio, a privately held, ...
Investing.com -- Ipsen (EPA:IPN) stock tumbled 2% on Friday after the biopharmaceutical company announced that its Phase II FALKON trial for fibrodysplasia ossificans progressiva (FOP) failed to meet ...
Please provide your email address to receive an email when new articles are posted on . A retrospective study has concluded that any increase in the time interval between the occurrence of traumatic ...
In a new study published on 21 July 2023 by the journal Bone Research, a team of researchers from Johns Hopkins University, using a combination of lineage tracing and single-cell RNA sequencing (scRNA ...
Ipsen’s oral small molecule has failed to reduce the progression of a genetic disease that gradually turns tendons and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback